Lori Enney

526 total citations
7 papers, 140 citations indexed

About

Lori Enney is a scholar working on Rehabilitation, Neurology and Molecular Biology. According to data from OpenAlex, Lori Enney has authored 7 papers receiving a total of 140 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Rehabilitation, 3 papers in Neurology and 2 papers in Molecular Biology. Recurrent topics in Lori Enney's work include Stroke Rehabilitation and Recovery (4 papers), Botulinum Toxin and Related Neurological Disorders (3 papers) and Nerve injury and regeneration (2 papers). Lori Enney is often cited by papers focused on Stroke Rehabilitation and Recovery (4 papers), Botulinum Toxin and Related Neurological Disorders (3 papers) and Nerve injury and regeneration (2 papers). Lori Enney collaborates with scholars based in United States, United Kingdom and India. Lori Enney's co-authors include Steven C. Cramer, Bruce H. Dobkin, Elizabeth A. Noser, Monica Simeoni, Thomas R. Thompson, Bams Abila, Nicola Scott, Saege Hancock, Michael Warren and Vincent Procaccio and has published in prestigious journals such as Neurology and Stroke.

In The Last Decade

Lori Enney

7 papers receiving 135 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lori Enney United States	5	85	60	40	40	28	7	140
Justyna Zielińska-Turek Poland	5	34 0.4×	38 0.6×	47 1.2×	29 0.7×	8 0.3×	13	129
Dario Pfyffer Switzerland	10	23 0.3×	23 0.4×	19 0.5×	16 0.4×	46 1.6×	23	262
Ignacio Álvarez Spain	10	9 0.1×	28 0.5×	79 2.0×	38 0.9×	27 1.0×	27	172
Juntao Feng China	8	35 0.4×	40 0.7×	66 1.6×	13 0.3×	85 3.0×	28	295
Krystian Figlewski Denmark	7	82 1.0×	105 1.8×	24 0.6×	6 0.1×	19 0.7×	9	174
Marta Bilik Poland	4	89 1.0×	110 1.8×	26 0.7×	6 0.1×	21 0.8×	6	135
Wen-Dong Xu China	9	33 0.4×	46 0.8×	85 2.1×	6 0.1×	68 2.4×	12	278
Levke Steiner Switzerland	3	77 0.9×	95 1.6×	16 0.4×	6 0.1×	10 0.4×	3	146
Stephen Wørlich Pedersen Denmark	10	12 0.1×	91 1.5×	174 4.3×	12 0.3×	16 0.6×	12	284
Ileok Jung South Korea	9	12 0.1×	98 1.6×	69 1.7×	23 0.6×	49 1.8×	19	240

Countries citing papers authored by Lori Enney

Since Specialization

Citations

This map shows the geographic impact of Lori Enney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori Enney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori Enney more than expected).

Fields of papers citing papers by Lori Enney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori Enney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori Enney. The network helps show where Lori Enney may publish in the future.

Co-authorship network of co-authors of Lori Enney

This figure shows the co-authorship network connecting the top 25 collaborators of Lori Enney. A scholar is included among the top collaborators of Lori Enney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori Enney. Lori Enney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Cramer, Steven C., et al.. (2017). Proof-of-Concept Randomized Trial of the Monoclonal Antibody GSK249320 Versus Placebo in Stroke Patients. Stroke. 48(3). 692–698. 28 indexed citations

2.

Dobkin, Bruce H., et al.. (2014). Predictors and Biomarkers of Treatment Gains in a Clinical Stroke Trial Targeting the Lower Extremity. Stroke. 45(8). 2379–2384. 37 indexed citations

3.

Cramer, Steven C., et al.. (2013). A Single-Blind Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Repeat Doses of GSK249320 in Patients with Stroke (S52.005). Neurology. 80(7_supplement). 1 indexed citations

4.

Cramer, Steven C., Bams Abila, Nicola Scott, Monica Simeoni, & Lori Enney. (2013). Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Repeat Doses of GSK249320 in Patients With Stroke. Stroke. 44(5). 1337–1342. 24 indexed citations

5.

Cramer, Steven C., et al.. (2009). BDNF Polymorphism and Clinical Outcome in the GAIN Trials. Stroke. 40(4). 1 indexed citations

6.

Cramer, Steven C., et al.. (2009). Randomized, Placebo-Controlled, Double-Blind Study of Ropinirole in Chronic Stroke. Stroke. 40(9). 3034–3038. 40 indexed citations

7.

Cramer, Steven C., et al.. (2008). Ropinirole in the treatment of motor deficits after stroke: A randomized, placebo-controlled, double-blind study. Stroke. 39(2). 542–542. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact